TRAVOPROST

作品数：17被引量：3H指数：1
导出分析报告
相关领域：医药卫生更多>>
相关作者：程金伟魏锐利更多>>
相关机构：第二军医大学北京协和医学院更多>>
相关期刊：《Chinese Medical Journal》《Open Journal of Ophthalmology》《Case Reports in Clinical Medicine》《Chinese Medical Sciences Journal》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Clinical Observation of Carteolol Hydrochloride Eye Drops Combined with Travoprost Eye Drops in the Treatment of Open-Angle Glaucoma
《Journal of Clinical and Nursing Research》2024年第11期191-197,共7页Fangning Wang 
Objective:To analyze the therapeutic effects of carteolol hydrochloride(CAR)eye drops combined with travoprost(TRA)eye drops in the treatment of open-angle glaucoma(OAG).Methods:A total of 72 OAG patients(87 eyes)hosp...
关键词：Carteolol hydrochloride eye drops Travoprost eye drops Open-angle glaucoma Visual acuity Intraocular pressure 
Acute Uveitis in Neovascular Glaucoma Patient after a Single Dose of Travoprost
《Case Reports in Clinical Medicine》2024年第8期275-282,共8页Lijun Wang Jing Zhu Qian Feng Junfeng Yang 
A 38-year-old man with no history of uveitis developed neovascular glaucoma (NVG) due to proliferative diabetic retinopathy (PDR). He had a history of ocular surgery with placement of glaucoma drainage implants (GDI),...
关键词：TRAVOPROST UVEITIS GLAUCOMA Prostaglandin Analogues Intraocular Pressure 
Improvement of MDA and SOD Expression and Optic Neuroprotection in Glaucoma Mice by Travoprost and β-Blocker
《Chinese Journal of Biomedical Engineering(English Edition)》2023年第2期73-78,共6页LIU Hai-hua LIN Yi-long ZHONG Jun-mu LIU Jian-qiang 
Objective:The goal of this study was to see if travoprost and β-blockers improved MDA and SOD expression as well as neuroprotection in glaucoma mice.Methods:One hundred healthy SPF SD rats were randomly allocated int...
关键词：TRAVOPROST Β-BLOCKER glaucoma optic nerve protection 
AB082.Gold nanoparticles as a new drug vector for glaucoma therapy
《Annals of Eye Science》2018年第1期488-488,共1页Florence Masse Mathieu Ouellette Elodie Boisselier 
Background:Glaucoma is an optical neuropathy affecting over 67 million people in the world.Efficiency of current active molecules,as travoprost(hydrophobic)is limited when administered by ophthalmic drops.Indeed,more ...
关键词：Gold nanoparticles drug vector GLAUCOMA TRAVOPROST 
Efficacy and Safety of Travoprost and Timolol Fixed Combination Compared to Travoprost in Patients with Primary Open Angle Glaucoma and Ocular Hypertension
《Open Journal of Ophthalmology》2017年第3期176-183,共8页Gentian Hoxha Kelmend Spahiu Gazmend Kacaniku Mimoza Ismaili Fellanza Ismajli-Hoxha 
Purpose: To compare intraocular pressure (IOP)-lowering efficacy and safety of travoprost 0.004% and travoprost 0.004% and beta-blocker 0.5% fixed combination ophthalmic solution in patients with open-angle glaucoma a...
关键词：Open Angle Glaucoma Ocular Hypertension Travoprost/Timolol Fixed Combination Adverse Event 
Impact of Combination Use of 0.004% Travoprost and 2% Pilocarpine on Matrix Metalloproteinases Synthesized by Rabbit Ciliary Muscle:a Pilot Study
《Chinese Medical Sciences Journal》2013年第4期229-232,共4页Shun-hua Zhang Jia-liang Zhao 
Objective To explore the impact of combination use of prostaglandin analogue and cholinergic agonists on main matrix metalloproteinases(MMPs)synthesized by albino rabbit ciliary muscle.Methods Normal adult albino rabb...
关键词：matrix metalloproteinases prostaglandin analogue PILOCARPINE 
Comparative Evaluation of the Efficacy of the Bimatoprost 0.03%, Brimonidine 0.2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0.004%/Timolol 0.5%-Fixed Combinations in Patients Affected by Open-Angle Glaucoma
《Open Journal of Ophthalmology》2012年第4期122-126,共5页Italo Giuffre 
Purpose: This is a retrospective, comparative, head-to-head, not commissioned study about the efficacy of bimato-prost 0.03%, brimonidine 0.2%, brinzolamide 1%, dorzolamide 2%, and travoprost 0.004%/timolol 0.5%-fixed...
关键词：BIMATOPROST 0.03% BRIMONIDINE 0.2% Brinzolamide 1% DORZOLAMIDE 2% TRAVOPROST 0.004%/Timolol 0.5% Fixed Combinations EFFICACY IOP 
Intraocular pressure lowering efficacy and safety of travoprost 0.004 % as a replacement therapy in patients with open angle glaucoma or ocular hypertension被引量：2
《Chinese Medical Journal》2010年第11期1417-1421,共5页GE Jian SUN Xing-huai WANG Ning-li ZHAO Jia-liang WU Ling-ling CHEN Xiao-ming WANG Zhi-xin Benny Li 
Background Travoprost has been widely used for the treatment of patients with open-angle glaucoma （OAG） or ocular hypertension （OH）. The aim of this study was to evaluate the intraocular pressure （lOP） lowering ...
关键词：TRAVOPROST prostaglandin analogue intraocular pressure GLAUCOMA 
在猴青光眼治疗中Bimatoprost或travoprost与拉坦前列腺素叠加效果
《美国医学会眼科杂志（中文版）》2005年第2期128-128,F0003,共2页Donna J. Gagliuso Rong-Fang Wang Thomas W. Mittag Steven M. Podos 刘敬（译） 
目的：比较市售药物Bimatoprost或travoprost加上拉坦前列腺紊治疗激光诱导的单侧猴青光眼的降眼压疗效。
关键词：BIMATOPROST 拉坦前列腺素 青光眼治疗 叠加 猴 激光诱导 降眼压 
前列腺素F2a激动剂曲伏前列素travoprost
《中国医药技术与市场》2005年第2期53-54,共2页
一、简介 商品名Travatan，开发与上市厂商，本品由美国Alcon研制，于2001年3月首次在巴西和委内瑞拉上市。
关键词：前列素 激动剂 前列腺素 首次 上市 商品名 简介 研制 厂商 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部